Ross Margulies, JD, MPH

A rule from CMS requires, in part, that Medicare Advantage organizations and Medicare Part D plan sponsors have the ability to obtain data.

The specialty pharmacy community should remain alert in the coming months as the MEDCAC receives public comments and considers the future of Medicare coverage for 2 major therapies. The MEDCAC decision can have far-reaching impact on patient access.

Incentives in the 2010 health care law have encouraged consolidation in the health care marketplace toward a more cost-conscious managed health care market.

Compliance with the much-anticipated implementation of the "Sunshine Act" will impact specialty pharmacies nationwide. Our experts take a closer look at the potential changes and how they will affect the industry now and in the future.

The specialty pharmacy community should be prepared for legislation that could alter the supply and distribution of specialty pharmaceuticals.

New rules related to Health Insurance Exchanges as part of the health care reform law are examined, as they signal the potential for a dramatic shift in the insurance market.